other material
confidence high
sentiment neutral
materiality 0.65
TriSalus launches exchange offer for Series A Preferred, up to 11.9M common shares
TriSalus Life Sciences, Inc.
- Offers up to 11,860,206 common shares in exchange for each share of Series A Convertible Preferred at $4.00 per share based on liquidation preference plus accrued dividends through Aug 10, 2027.
- Consent solicitation seeks amendment to automatically convert remaining Preferred after offer closes at a ratio 11.3% lower than exchange offer.
- Holders representing ~55% of outstanding Preferred have agreed to tender and consent via Tender and Support Agreements.
- Expiration date: 12:01 a.m. ET on July 23, 2025; shares can be withdrawn anytime before.
- 3,594,002 Preferred shares outstanding as of June 13, 2025; Preferred stock not publicly traded.